|
|
IN3 events bring together early/mid/late-stage, medical technology innovators with investors, venture capitalists, and business development executives - all in a single forum. Network with the biggest, medical device dealmakers in financing, partnering, and M&A!
Altea Therapeutics
Altea Therapeutics is developing transdermal patches that deliver therapeutic levels of water-soluble biological drugs and low molecular weight drugs as an alternate to needle injection or infusion.
-
Apogee Aesthetic Technologies
Novel minimally invasive device for midface lift and other lift procedures.
-
Avantis Medical Systems, Inc.
A commercial stage visualization technology company focused on delivering cost-effective solutions for the improved detection and prevention of cancer in the gastrointestinal (GI) tract.
-
Biomedica
BIOMEDICA Management Corp Focusing on next generation biologic devices for high volume hemorrhage and sepsis.
-
Capnia, Inc.
Capnia, located in Palo Alto, California, is developing a novel medical device for the symptomatic treatment of rhinitis (allergies).
-
CardioMag Imaging, Inc.
Non-invasive devices to identify patients with coronary artery disease and other life threatening cardiovascular conditions.
-
CeQur, Ltd.
CeQur's produces a small, wearable insulin device that delivers basal and bolus doses subcutaneously. It enables patients to easily comply with insulin regimens, including intensive insulin therapy.
-
Control Medical Technology
Control Medical Technology offers a 510K cleared aspiration system (with issued patents) for use in thrombus removal, rotational vacuum assisted biopsy, tissue resection, and spinal disc decompression.
-
CytoPherx, Inc.
Inflammation-based diseases and conditions with a proprietary selective cytopheresis system.
-
D.S. Biomedical, LLC
The product is an Electronic Biofeedback stimulation device that analyzes and also treats. There are five different units, two devices have patents pending and there are seven registered trademarks.
-
e-Zassi, LLC
e-Zassi has launched the first software service in the world that materially speeds medical device industry transaction times while also providing automated and predictive device technology diligence and confidentiality protection for all parties.
-
EndoGastric Solutions, Inc.
Minimally invasive surgical procedures for the treatment of gastroenterological diseases.
-
EndoPhlebex Technologies, Inc.
EndoPhlebex Technologies, Inc. offers varicose vein stripping under direct vision for ablation of the diseased saphenous vein in a kit that reduces trauma, minimizes bleeding and expects improved clinical outcomes.
-
EndoSphere Surgical, Inc.
EndoSphere Surgical, Inc. is developing a novel platform technology aimed at advances in micro-laparoscopic surgery that improves hand-eye coordination resulting in improved cosmetic benefits using one fewer surgical port.
-
Epinex Diagnostics, Inc.
Epinex specializes in the development of innovative rapid tests that target major deficiencies in existing healthcare markets. The G1A™ is a patented, rapid test that uses glycated albumin to monitor diabetes more effectively.
-
Eye Sonix
Developing a new method of treating open angle glaucoma using a non-invasive ultrasound device.
-
Freedom Meditech Inc.
Developing and commercializing 2 non-invasive ophthalmic medical device products for diabetes screening and daily diabetes glucose monitoring.
-
Freshmedx
Freshmedx based in Salt Lake City, Utah has developed an innovative new medical diagnostic system for the early detection of lung cancer.
-
GeneEx, Inc.
GeneEx is developing rapid, point-of-care saliva tests for infectious diseases capable of detecting virulence markers produced only during active infections.
-
Graft-Loc
Graft-Loc is a debt-free, early stage device company focused on vascular connections for use in CABG & vascular surgeries. Graft-Loc's patented device creates a reliable anastomosis to any graft site.
-
GT Urological, LLC
GT Urological, LLC (GTU) is an emerging, clinical stage, medical device company focused on developing proprietary products for the urinary incontinence market.
-
Infusion Innovations, Inc.
Founded in 2006, I3 has a strong proprietary portfolio of products ranging from needle-less injection site connectors, to safety syringes, and biodiagnostic sampling devices.
-
IVDiagnostics, LLC
Develop, test and market more effective diagnostic tools for addressing rare circulating tumor cells.
-
LumaMed
LumaMed provides a web based service platform enabled by a proprietary imaging technology for the remote evaluation of skin cancer.
-
Magellan Spine Technologies
Magellan is developing minimally invasive lumbar annular repair technologies to prevent disc reherniation and interrupt disc degeneration.
-
MenRx Surgical, LLC
MenRx Surgical markets the Pro-Vas Occlusion Device which provides men seeking a permanent form of contraception with a less-invasive alternative to vasectomy.
-
NeoVista, Inc.
NeoVista, Inc. has a minimally invasive surgical technology that uses ionizing radiation to treat Age-Related Macular Degeneration (ARMD).
-
Orasi Medical
Orasi Medical, a recent university spinoff that's developing technology to help quickly diagnose neurological diseases like Alzheimer's.
-
Orthosensor, Inc.
Orthosensor is an early-stage device company developing “Intelligent Orthopedic Devices” that will address the growing clinical and economic cost of orthopedic implant failure and osteoporosis.
-
PEAK Surgical, Inc.
Technology provides the precision of a scalpel and the bleeding control of traditional electrosurgery without extensive collateral tissue damage.
-
PolyMedix, Inc.
PolyMedix is developing novel, first in class therapies for serious, life threatening, acute disorders.
-
Portable Health Device
The Portable Health Device is a very robust patient, provider and insurer application on a simple USB flash drive.
-
PortaScience, Inc.
Our core technologies enable us to develop non-instrumented devices, for a broad range of diagnostic and monitoring tests which are accurate and low cost.
-
Soft Tissue Regeneration, Inc.
Soft Tissue Regeneration, Inc. has developed a biocompatible and biodegradable scaffold to regenerate the anterior cruciate ligament ("ACL") of the knee.
-
SquareOne Inc.
SquareOne is commercializing a highly differentiated aorto-ostial stent and delivery platform with strong IP for both peripheral and coronary application.
-
Thermimage, Inc.
A noninvasive diagnostic medical device that replaces the current traumatic procedure used to detect pediatric VUR (urinary reflux) and prevent kidney damage in 4MM children annually.
-
Vertos Medical
Pioneered the MILD™ (Minimally Invasive Lumbar Decompression) procedure which may be performed in conventional operating rooms or interventional radiology suites with fluoroscopic imaging.
-
VitalWear, Inc.
Provides affordable thermal systems that are portable, easy-to-use and comfortable to wear.
-
April 28-30, 2010
The Marriott Rive Gauche
Paris, France
www.IN3Europe.com
-
June 9-11, 2010
The Westin Copley Place
Boston, MA - USA
www.IN3East.com
-
October 27-29, 2010
San Francisco, CA - USA
| IN3 Investor Day - March 3 |
IN3 Main Event - March 4-5 |
| Investor Day is key for medtech innovators who are interested in what investment leaders in the industry are thinking, doing, and planning. Venture and investment officials will speak about what interests them most in medical device technologies, therapeutic areas, products, and geographic markets. They will also discuss partnering opportunities, how to maximize visibility in front of large company investors, and the role of M&A.
|
The Main Event is designed for those in the business development and/or financial community who are interested in investment or partnering opportunities with medtech innovators. Medtech innovators give 10-minute presentations on their latest medical device innovations within a wide range of high-growth markets. In between presentation blocks, enjoy dedicated break-out sessions for one-on-one meetings, and networking. |
- Nearly 50 presentations by medical technology innovators with the most desired technologies.
- 20+ finance presentations and perspectives by some of the industry's biggest players.
- Over two dozen networking opportunities.
- Partnering Software to identify attendees and plan private, 1-on-1 meetings in advance – all without schedule overlap or program interrupt.
- Multiple keynote plenary panels on the latest 'deals' case studies, device investing, M&A, health reform, clinicians, and more!
- Access to current and future news on investing and partnering, as driven by Elsevier Business Intelligence researchers, analysts, and authors.
Over 1,500 emerging medical technology company presenters and more than 8,000 attendees have participated at IN3 events over the past nine years. We are very proud to say that many young companies have worked their way up the funding ladder and into the marketplace via the relationships they formed at IN3 events. Click Here for success stories and testimonials from our past presenters and attendees.
| Why Use Windhover Conferences Partnering Software? |
- • Identify attendees to choose potential partners.
- • Search database of partnering/investing opportunities(including deal history and related articles).
- • Communicate and pre-schedule as many meetings as you wish with fellow attendees.
- • Showcase your company's innovative technology and investment/partnering interests.
|
For more information, please contact:
Kristy Grimes at 1-480-985-9512 or Kayleen Kell at 1-888-290-2225 (USA only), or email IN3@Elsevier.com.
| Important Deadlines |
Save $100 before: |
02/12/2010 |
| Last Chance for Discounted Rooms (may sell out earlier) |
02/09/2010 |
| Partnering Opens (start scheduling meetings) |
02/10/2010 |
| Innovator Company Profile Due |
02/10/2010 |
Click Here to view full pricing schedule.
Who Attends
- • Presidents, CEOs, CTOs, COOs
- • Founders, Chairpersons
- • Venture Partners
- • Managing Directors
- • VPs/Directors of Strategic Planning, Business Development, Marketing, New Technology, Acquisitions, R&D, & Sales
- • Senior Investment
- • Analysts/Principals/Directors
- • Established device companies seeking technology via licensing, partnering, and acquisition to broaden or deepen product lines or build sector strength.
- • VCs and investment bankers.
- • Medical device, biopharmaceutical, biotech, or other company executives seeking investments or partnerships.
Benefits of Attending
Potential acquirers/funding partners can meet and screen over 50 hand-selected, first-rate investment possibilities in just two well-orchestrated days, via focused presentations covering widely varied technologies, stages of development and testing, potential markets, management teams, regulatory timeline, patent protection, competitive strategy, funding desired, and much more... Including private break-out sessions and networking events.
Medical device start-ups face intense competition for a finite amount of available capital funding. This makes IN3 events the ideal setting for emerging companies to meet and impress potential investors from many of the top-tier device companies and discerning healthcare investment firms from around the world.
All attendees will gain a keen under-standing (in a short timeframe) of the emerging medical technologies that are on track to make a distinct impact on the intensely-competitive device industry.
Advisory Board
- Annette Campbell-White
Senior Managing Member
MedVenture Associates
- Michael Carusi
General Partner
Advanced Technology Ventures
- Luke Evnin
General Partner
MPM Capital
- Richard M. Ferrari
Managing Director
DeNovo Ventures
- William T. Harrington
Partner
Three Arch Partners
- Ross A. Jaffe
Managing Director
Versant Ventures
- Josh Makower
Venture Partner
NEA
- John Maroney
General Partner
Delphi Ventures
- Allan May
Chairman, Founder
Life Science Angels
Managing Director
Emergent Medical Partner
- David Milne
Managing Partner
SV Life Science Advisers
- Trevor J. Moody
Partner
Frazier Healthcare Ventures
- Jesse I Treu
Partner
Domain Associates
|
|